Slideshow
Update on Stroke Risks
Author(s):
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
New neurology research indicates cirrhosis is linked to increased stroke risk, particularly hemorrhagic stroke, and that herpes zoster infection significantly raises the risks of stroke and MI. And the insomnia drug zolpidem may treat a variety of neurologic disorders.
Related Videos
Tailoring Precision Medicine Treatment of Hemorrhagic Stroke Through Predictive Models: Kara R. Melmed, MD
Enhancing Brain Plasticity by Personalized and Closed-Loop Neuromodulation: Roy H. Hamilton, MD, MS, FAAN
Evolving Evidence and Clinical Confidence for Blood Pressure Management in Intracerebral Hemorrhage: Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Exploring Noninvasive Brain Stimulation for Neurorehabilitation: Roy H. Hamilton, MD, MS, FAAN
The Key Role of Early and Balanced Blood Pressure Control in ICH Management: Kara R. Melmed, MD
Aggressive Blood Pressure Lowering for Intracerebral Hemorrhage Management: Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Nuances in Thrombectomy Techniques and Anesthesia Use for Stroke: J Mocco, MD, MS
Innovation in Stroke Care and Expanding the Treatment Windows: Keith Churchwell, MD, FAHA, FACC, FACP
Lessons Learned From the 2025 International Stroke Conference: Keith Churchwell, MD, FAHA, FACC, FACP
Key Considerations When Incorporating Stroke Trial Data Into Clinical Practice: J Mocco, MD, MS
Related Content
